Studies show that compared to healthy controls, PD-MCI patients exhibit a 45% decrease in raphe SERT binding, which is positively correlated with Conners’ Continuous Performance Test (CPT) scores. This evidence concerns the gene SLC6A4 and Parkinson disease.